Eisai reports JPY 234.33 billion revenue: Eisai stock stood 6.16 percent below high

Eisai reported JPY 234.33 billion in fiscal first-quarter revenue, up 15.60 percent year over year, in figures published on August 3, 2026. The company's Tokyo Stock Exchange price was last at JPY 4,920.00 on October 16, 2026 at 3:30 p.m. JST, up 1.07 percent versus the prior close.

Revenue growth sets the tone

Eisai's investor relations materials list the fiscal first-quarter report dated August 3, 2026. Operating profit reached JPY 24.70 billion for the quarter ended June 30, 2026, while net income attributable to common shareholders came to JPY 18.24 billion. The figures put operating profit at 10.54 percent of revenue, based on the reported amounts.

The operating result gives the market a more useful comparison than revenue alone. Revenue rose 15.60 percent year over year, while the first-quarter operating result reflects the cost base behind Eisai's product portfolio and research program.

Stock sits below the yearly high

Eisai's 52-week range was JPY 3,660.00 to JPY 5,243.00 as of October 16, 2026. The last price stood 6.16 percent below the yearly high and 34.43 percent above the yearly low. Trading volume reached 1,242,900 shares against an average of 1,369,101 shares.

The valuation frame is also measurable. Eisai's market capitalization was JPY 1.4 trillion, its P/E was 32.78 and its dividend yield was 0.03 percent on October 16, 2026. In an October 16 analysis, Simply Wall St placed fair value at JPY 4,582, 6.87 percent below the last price.

Comparison with peers

Eisai (Tokyo Stock Exchange, JPY): plus 1.07 percent, P/E 32.78, market capitalization JPY 1.4 trillion.

Takeda Pharmaceutical (Tokyo Stock Exchange, JPY): plus 0.65 percent, P/E 55.47, market capitalization JPY 9.9 trillion.

Daiichi Sankyo (Tokyo Stock Exchange, JPY): plus 3.38 percent, P/E 20.76, market capitalization JPY 5.0 trillion.

Price remains the immediate reference

The Tokyo quotation gives investors a clear dated market marker while the latest fiscal-quarter figures provide the operating backdrop. The next comparison point is whether revenue growth can translate into sustained operating earnings as Eisai advances its neurology and oncology portfolio.

Eisai was last at JPY 4,920.00 on the Tokyo Stock Exchange on October 16, 2026 at 3:30 p.m. JST, up 1.07 percent versus the prior close.

Market context: Market report Nikkei 225.

More news and analyses on Eisai stock